Download PDF
Klin Monbl Augenheilkd 2016; 233(04): 508-510
DOI: 10.1055/s-0042-102610
Der interessante Fall
Georg Thieme Verlag KG Stuttgart · New York

Radiation Retinopathy 15 Years after Orbital Irradiation for Thyroid Orbitopathy

Strahlenretinopathie 15 Jahre nach Orbita-Bestrahlung bei endokriner Orbitopathie
K. Hurtikova   *
1   Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)
,
G. von Arx
2   Admedico Augenzentrum, Olten, Switzerland (Director: Dr. Georg von Arx)
,
N. Fichter
2   Admedico Augenzentrum, Olten, Switzerland (Director: Dr. Georg von Arx)
,
H. Gerding   *
1   Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)
3   Department of Ophthalmology, University of Münster, Münster (Director: Prof. Dr. Nicole Eter)
› Author Affiliations
Further Information

Publication History

Publication Date:
26 April 2016 (online)

Also available at
    Permissions and Reprints

Corrected by:

Radiation Retinopathy 15 Years after Orbital Irradiation for Thyroid OrbitopathyKlin Monbl Augenheilkd 2016; 233(04): e2-e2
DOI: 10.1055/s-0042-114043

Introduction

Orbital irradiation (OR) is the second choice therapy in cases with early and acute thyroid orbitopathy [1], [2], [3]. OR may improve ocular motility, but is not effective against exophthalmos and long-standing eye muscle dysfunction. Intravenous glucocorticosteroid pulse therapy seems to offer the greatest therapeutical impact on thyroid orbitopathy and is therefore regarded as the first choice therapeutical option [4]. A combination of both, oral glucocorticosteroids and orbital radiation therapy may have a synergistic effect [5], [6] and was previously discussed as a first choice alternative to oral corticosteroids alone. Evidence that the combination of OR with intravenous glucocorticosteroid pulse therapy may be more efficient than glucocorticosteroid therapy alone is still missing. Generally, orbital radiation according to the commonly used protocol (20 Gy 10 × 2 Gy fractions over 2 weeks [7] is regarded as relatively safe. In the case reported here radiation retinopathy (RRP) was diagnosed 15 years after unilateral orbital irradiation according to the commonly used protocol in thyroid orbitopathy.

* Both Authors equally contributed to this publication.


 

  • References

  • 1 Bradley EA, Gower EW, Bradley DJ et al. Orbital radiation for Graves ophthalmopathy. A report by the American Academy of Ophthalmology. Ophthalmology 2008; 115: 398-409
    CrossrefPubMedGoogle Scholar
  • 2 Tanda ML, Bartalens L. Efficacy and safety of orbital radiotherapy for Gravesʼorbitopathy. J Clin Endocrinol Metab 2012; 97: 3857-3865
    CrossrefPubMedGoogle Scholar
  • 3 Viani GA, Boin AC, De Fendi LI et al. Radiation therapy for Gravesʼ ophthalmopathy: a systemic review and meta-analysis of randomized controlled trials. Arq Bras Oftalmol 2012; 75: 324-332
    CrossrefPubMedGoogle Scholar
  • 4 Bartalena L, Baldeschi L, Dickinson A et al. Consensus statement of the European Group on Gravesʼorbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008; 158: 273-285
    CrossrefPubMedGoogle Scholar
  • 5 Bartalena L, Marcocci C, Chiovato L et al. Orbital cobalt irradiation combined with systemic corticosteroids for Gravesʼs ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983; 56: 1139-1144
    CrossrefPubMedGoogle Scholar
  • 6 Marcocci C, Bartalena L, Bogazzi F et al. Orbital radiotherapy combined with high-dose systemic glucocorticosteroids for Graveʼs ophthalmopathy in more effective than orbital radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 1991; 14: 853-860
    CrossrefPubMedGoogle Scholar
  • 7 Donaldson SS, Bagshaw MA, Driss JP. Supervoltage orbital radiotherapy for Gravesʼ ophthalmopathy. J Clin Endocrinol Metab 1973; 37: 276-285
    CrossrefPubMedGoogle Scholar
  • 8 Kinyoun JL, Kalina RE, Brower SA et al. Radiation retinopathy after orbital irradiation for Gravesʼ ophthalmopathy. Arch Ophthalmol 1984; 102: 1473-1476
    CrossrefPubMedGoogle Scholar
  • 9 Kinyoun JL, Chittum ME, Wells CG. Photocoagulation treatment of radiation retinopathy. Am J Ophthalmol 1988; 105: 470-478
    CrossrefPubMedGoogle Scholar
  • 10 Kinyoun JL, Orcutt JC. Radiation retinopathy. JAMA 1987; 258: 610-611
    CrossrefPubMedGoogle Scholar
  • 11 Marquez SD, Lum BL, McDougall IR et al. Long-term results of irradiation for patients with progressive Gravesʼ ophthalmopathy. Int J Radiat Oncol Biol Phys 2001; 51: 766-774
    CrossrefPubMedGoogle Scholar
  • 12 Robertson DM, Buettner H, Gorman CA et al. Retinal microvascular abnormalities in patients treated with external radiation for Graves ophthalmopathy. Arch Ophthalmol 2003; 121: 652-657
    CrossrefPubMedGoogle Scholar
  • 13 Gorman CA, Garrity JA, Fatourechi V et al. The aftermath of orbital radiotherapy for Gravesʼ ophthalmopathy. Ophthalmology 2002; 109: 2100-2107
    CrossrefPubMedGoogle Scholar
  • 14 Marcocci C, Bartanlena L, Roccchi R et al. A long-term safety of orbital radiotherapy for Gravesʼ ophthalmopathy. J Clin Endocrinol Metab 2003; 88: 3561-3566
    CrossrefPubMedGoogle Scholar
  • 15 Wakelkamp IM, Tan H, Saeed P et al. Orbital irradiation for Gravesʼ ophthalmopathy. Is it safe? A long-term follow-up study. Ophthalmology 2004; 111: 1557-1562
    CrossrefPubMedGoogle Scholar
  • 16 Kaushik M, Pulido JS, Schild SE, Stafford S. Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Int J Radiat Oncol Biol Phys 2012; 84: 1145-1150
    CrossrefPubMedGoogle Scholar
  • 17 Monroe AT, Bhandare N, Morris CG et al. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005; 61: 856-864
    CrossrefPubMedGoogle Scholar
  • 18 Parsons T, Bova FJ, Fitzgerald CR et al. Radiation retinopathy after external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30: 765-773
    CrossrefPubMedGoogle Scholar